Clinical Trials Logo
  1. Home
  2. Bone Tumor
  3. NCT05631002
  4. Details
NCT05631002 Clinical Trial

Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors

Bone Tumor Clinical Trial

Official title:
Chemical Shift Encoding-based Water-fat Magnetic Resonance Imaging in Spinal Tumors

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05631002
Other study ID # M2022403
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2022
Est. completion date December 31, 2023

Study information
Verified date August 2022
Source Peking University Third Hospital
Contact Qizheng Wang
Phone 13161593501
Email wangqizheng96@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Fat composition of the spinal tumors is positively correlated with classification and differential diagnosis of benign and malignant tumors.

Description:

Chemical shift encoding-based water-fat magnetic resonance imaging (MRI) is a non-invasive method that provides quantitative information about the biochemical water-fat composition of bone marrow and skeletal muscle in vivo.

Recruitment information / eligibility
Status Recruiting
Enrollment 150
Est. completion date December 31, 2023
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Pathological biopsy of a patient with diagnosed spinal tumor lesion, and preoperative examination Chemical shift encoding-based water-fat MRI was performed. Exclusion Criteria: - Recurrent neoplasms; Lesion diameter < 1 cm; Poor image quality.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Chemical shift encoding-based water-fat MRI
Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method

Locations
Country Name City State
China Peking University third hospital Beijing Beijing

Sponsors (1)
Lead Sponsor Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Type of tumor Pathological diagnosis One month before treatment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05515068 - Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Completed NCT02862288 - Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Phase 1/Phase 2
Withdrawn NCT01679691 - The Epidural Anesthesia on the Intra-operative and Post-operative Amount of Bleeding Post Lower Limb Salvage Surgery N/A
Recruiting NCT04178044 - Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection Phase 1
Completed NCT03389724 - Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia Phase 3
Completed NCT05075889 - Utility of ICG in Benign Bone Tumors Early Phase 1
Completed NCT04755140 - Endoprosthesis Metal Toxicity Study
Not yet recruiting NCT03427632 - Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors N/A
Completed NCT04798326 - Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults Phase 1
Recruiting NCT06459141 - The Effect of Hemodilution on Intraoperative Allogeneic Transfusion (HEAL) N/A
Not yet recruiting NCT06453642 - Evaluation of a Simple-Prep Controlled Embolic N/A
Active, not recruiting NCT04104750 - The Assessment of Fatigue and Quality of Life in Patients With Bone Tumor,
Completed NCT00598741 - Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors N/A
Completed NCT02398058 - Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) Phase 1
Recruiting NCT06171282 - A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors Early Phase 1
Not yet recruiting NCT06376682 - EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy N/A
Enrolling by invitation NCT05772312 - Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
Recruiting NCT06455722 - [68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors Early Phase 1
Recruiting NCT05779670 - Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery
Completed NCT05732558 - Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy N/A